The project was awarded over $300,000 in funding from MIT’s Deshpande Innovation Center in 2012 and 2013 to support... read more

Privo Technologies expands to a new 3000 square foot facility just outside of Boston, MA. Located at 200 Corporate... read more

Privo Technologies is proud to serve as both an exhibitor and selected speaker at the RESI conference in Boston... read more

​​​​​Privo Technologies (Privo) has been selected for the prestigious Phase IIB Bridge Award from the National Cancer Institute (NCI). The NCI... read more

Privo Technologies is honored to receive a Phase 2 award for $2M from the NIDCR SBIR program to further develop its scale-up, chemistry, and manufacturing program. read more

Privo Technologies (Privo), a Massachusetts-based company with roots in the Langer lab at MIT, has been selected to introduce... read more

Privo Technologies (Privo), a Leader in the Field of Novel, Nanotechnology-Based Localized Oncology Treatments, is Pleased to Announce the... read more

The Salisbury Award Competition is a set of competitions participated in by investigators at major cancer research institutions and/or scientists... read more

Privo Technologies is pleased to announce that the company has won the 2016 National Tibbetts award for outstanding contributions... read more

Privo Technologies has been awarded ~$2 million in funding from the FDA through its Office of Orphan Product Development... read more